Loading…
Loading…
Sorrento Voyage has announced the expansion of its private boat tours and romantic proposal experiences across the Amalfi Coast and Capri, offering travelers personalized sea-based journeys led by its founding team. Sorrento, Italy--(Newsfile Corp. - January 5, 2026) - Sorrento Voyage, a private charter company based in Piano di Sorrento, has expanded its range of bespoke luxury boat tours and romantic experiences along the Amalfi Coast, responding to growing demand for intimate, experience-led travel in Southern Italy.
Institutional and Insider Ownership 63.2% of Cortexyme shares are owned by institutional investors. Comparatively, 0.0% of Sorrento Therapeutics shares are owned by institutional investors. 27.9% of Cortexyme shares are owned by insiders. Comparatively, 2.6% of Sorrento Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money
Institutional and Insider Ownership 0.0% of Sorrento Therapeutics shares are owned by institutional investors. Comparatively, 76.2% of NKGen Biotech shares are owned by institutional investors. 2.6% of Sorrento Therapeutics shares are owned by insiders. Comparatively, 10.4% of NKGen Biotech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments
Earnings and Valuation This table compares Sorrento Therapeutics and its rivals revenue, earnings per share and valuation. Gross Revenue Net Income Price/Earnings Ratio Sorrento Therapeutics $62.84 million -$572.84 million -0.01 Sorrento Therapeutics Competitors $41.99 million -$89.56 million -5.51 Sorrento Therapeutics has higher revenue, but lower earnings than its rivals. Sorrento Therapeutics is trading at a
Valuation and Earnings This table compares Sorrento Therapeutics and its peers top-line revenue, earnings per share (EPS) and valuation. Gross Revenue Net Income Price/Earnings Ratio Sorrento Therapeutics $62.84 million -$572.84 million -0.01 Sorrento Therapeutics Competitors $41.99 million -$89.56 million -5.73 Sorrento Therapeutics has higher revenue, but lower earnings than its peers. Sorrento Therapeutics is trading
Bremen, Indiana--(Newsfile Corp. - October 24, 2024) - Digger Specialties Inc. (DSI), a leading manufacturer of outdoor living products, is pleased to announce the addition of a 3-5/8" mesh infill option for the Westbury® Sorrento Mesh Railing effective November 1, 2024. Designed to provide a sophisticated, contemporary style that enhances the visual appeal of decks, balconies and porches, Westbury Sorrento Mesh Railing features unmatched long term durability and resistance to the elements.
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2024) - SORRENTO RESOURCES LTD. (CSE: SRS) (OTCQB: SRSLF) (the "Company") is pleased to announce that Mr.
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2024) - SORRENTO RESOURCES LTD. (CSE: SRS) (OCTQB: SRSLF) (the "Company") is pleased to announce that it has entered into a purchase agreement dated May 29, 2024 (the "Agreement") with Gold Hunter Resources Inc. (CSE: HUNT) ("Gold Hunter") for the sale of certain mineral claims around Gold Hunter's newly optioned MT property.
No recent filings indexed.